Home › Free Stock Grades › AMPH
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Grade
AMPH · Healthcare
B-
Market Cap
$1.3B
P/E Ratio
12.8
Revenue Growth (YoY)
-1.7%
Net Margin
13.6%
Return on Equity
12.4%
Dividend Yield
None
About Amphastar Pharmaceuticals, Inc.'s fundamentals
Amphastar Pharmaceuticals is a specialty and generic drug manufacturer with a market capitalization of $1.3 billion, trading at a P/E ratio of 12.8. The company maintains a solid net profit margin of 13.6% and generates a 12.4% return on equity, indicating efficient operations and reasonable profitability. However, revenue declined 1.7% year-over-year, suggesting the company faces near-term headwinds in the competitive pharmaceutical market. The company does not currently pay a dividend.